50242-215 : Xolair Pfs 150 mg/ml Subcutaneous Injection, Solution


NDC: 50242-215
Labeler: Genentech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Xolair Pfs
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA103976
Rev. Date: 


NDC Package Codes:

  • 50242-215-01: 1 SYRINGE, GLASS IN 1 CARTON (50242‑215‑01) > .5 ML IN 1 SYRINGE, GLASS
  • 50242-215-03: 1 SYRINGE, GLASS IN 1 CARTON (50242‑215‑03) / 1 ML IN 1 SYRINGE, GLASS
  • 50242-215-55: 1 SYRINGE, GLASS IN 1 CARTON (50242‑215‑55) / 1 ML IN 1 SYRINGE, GLASS
  • 50242-215-83: 1 SYRINGE, GLASS IN 1 CARTON (50242‑215‑83) / 1 ML IN 1 SYRINGE, GLASS
  • 50242-215-86: 1 SYRINGE, GLASS IN 1 CARTON (50242‑215‑86) > .5 ML IN 1 SYRINGE, GLASS
  • 50242-215-99: 1 SYRINGE, GLASS IN 1 CARTON (50242‑215‑99) / 1 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Omalizumab

Dosage Strength:

  • 150 mg/mL

Pharmaceutical Classes:

  • Anti-IgE [EPC]
  • Decreased IgE Activity [PE]
  • IgE-directed Antibody Interactions [MoA]

Related Products:

Based on records with the same trade name.
  • 50242-214 Xolair Pfs 75 mg/.5ml Subcutaneous Injection, Solution by Genentech, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50242-215 QR Code

< Prev: 50242-214Next: 50242-227 >

Related Discussions:

Xolair/Omalizumab-Hair Loss
I have been taking this medication for 5 month and I have experience a lot of hair loss. Spoke with a friend who is taki... 76 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.